Search results

It is used in the treatment of [[type II diabetes]]. {{As of|2007}}, it is one of only two oral anti-diabetics in the [[World ...ease in intracellular [[calcium]] in the [[beta cell]], which stimulates [[insulin]] release.

...etylcysteine may prevent contrast-medium–induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospita ...tp://diabetes.diabetesjournals.org/cgi/reprint/48/12/2398.pdf |doi=10.2337/diabetes.48.12.2398 |pmid=10580429 |issue=12}}</ref>

...stic ovary syndrome]] and has been investigated for other diseases where [[insulin resistance]] may be an important factor. ...has been conclusively shown to prevent the cardiovascular complications of diabetes. {{As of|2009}}, metformin is one of only two oral anti-diabetics in the [[

* [[Diabetes hypogonadism deafness mental retardation]] * [[Diabetes insipidus]]

...ablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus" JAMA 2009; 301: 1573-1579.</ref> Prognosis in HSCT varies widely dependent upon disease type, stage, stem cell source, HLA-matched status (for allogen

...or =Adams TE, Epa, VC ''et al''|title=Structure and function of the type 1 insulin-like growth factor receptor|journal=Cell Mol Life Sci|year=2000|volume=57|i ...Citation needed|date=March 2010}}&nbsp; Many disease processes, such as [[diabetes]], [[atherosclerosis|heart disease]], [[autoimmunity]], and [[cancer]] aris

...ts and ions, [[T-cell]] activation and [[pancreas|pancreatic]] beta-cell [[insulin]] release. In the search for new drugs, ion channels are a frequent target. ...rtant physiological processes such as the pacemaker activity in the heart, insulin release, and potassium uptake in [[glia|glial cells]]. They contain only t